source
- Excluding orphan drugs from Medicare pricing pilots could erase most savings, analysis showsA Harvard researcher has calculated that removing rare disease treatments from two Medicare pilot programs-GLOBE and GUARD-would dramatically cut the projected cost savings. The pilots are designe…
- Federal regulators hold closed-door meetings with tech firms to advance clinical AI adoptionFederal health officials, including the FDA, CMS and HHS, convened a closed-door "clinical AI demo day" to discuss how to safely expand the use of artificial intelligence in clinical settings. The…